Abstract
Hypofractionated image guided radiotherapy of extracranial targets has become increasingly popular as a treatment modality for inoperable patients with one or more small lesions, often referred to as stereotactic ablative body radiotherapy (SABR). This report details the results of the physical quality assurance (QA) program used for the first 33 lung cancer SABR radiotherapy 3D conformal treatment plans in our centre. SABR involves one or few fractions of high radiation dose delivered in many small fields or arcs with tight margins to mobile targets often delivered through heterogeneous media with non-coplanar beams. We have conducted patient-specific QA similar to the more common intensity modulated radiotherapy QA with particular reference to motion management. Individual patient QA was performed in a Perspex phantom using point dose verification with an ionisation chamber and radiochromic film for verification of the dose distribution both with static and moving detectors to verify motion management strategies. While individual beams could vary by up to 7 %, the total dose in the target was found to be within ±2 % of the prescribed dose for all 33 plans. Film measurements showed qualitative and quantitative agreement between planned and measured isodose line shapes and dimensions. The QA process highlighted the need to account for couch transmission and demonstrated that the ITV construction was appropriate for the treatment technique used. QA is essential for complex radiotherapy deliveries such as SABR. We found individual patient QA helpful in setting up the technique and understanding potential weaknesses in SABR workflow, thus providing confidence in SABR delivery.
Similar content being viewed by others
References
Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76(2):326–332
Siva S, MacManus M, Ball D (2010) Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 5(7):1091–1099
Fowler JF (1989) The linear–quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62(740):679–694
Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, Purdie T, Sadagopan R, Schell MC, Salter B, Schlesinger DJ, Shiu AS, Solberg T, Song DY, Stieber V, Timmerman R, Tome WA, Verellen D, Wang L, Yin FF (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37(8):4078–4101
Hurkmans CW, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Schuring D, Senan S (2009) Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the quality assurance working party of the randomised phase III ROSEL study. Radiat Oncol 4:1
Siva S, Chesson B, Aarons Y, Clements N, Kron T, MacManus M, Ball D (2012) Implementation of a lung radiosurgery program: technical considerations and quality assurance in an Australian institution. J Med Imaging Radiat Oncol 56(3):354–361
Solberg TD, Balter JM, Benedict SH, Fraass BA, Kavanagh B, Miyamoto C, Pawlicki T, Potters L, Yamada Y (2012) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pract Radiat Oncol 2(1):2–9
Kron T, Clements N, Aarons Y, Dunn L, Chesson B, Miller J, Roozen K, Ball D (2011) Radiochromic film for individual patient QA in extracranial stereotactic lung radiotherapy. Radiat Meas 46(12):1920–1923
Dunn L, Kron T, Johnston PN, McDermott LN, Taylor ML, Callahan J, Franich RD (2012) A programmable motion phantom for quality assurance of motion management in radiotherapy. Australas Phys Eng Sci Med 35(1):93–100
Andreo P, Burns DT, Hohlfeld K, Huq MS, Kanai T, Laitano F, Smith VG, Vynckier S (2000) Absorbed dose determination in external beam radiotherapy: an international Code of Practice for dosimetry based on standards of absorbed dose to water, In: IAEA technical report series no. 3982000, International Atomic Energy Agency, Vienna
Callahan J, Binns D, Dunn L, Kron T (2011) Motion effects on SUV and lesion volume in 3D and 4D PET scanning. Australas Phys Eng Sci Med 34(4):489–495
Callahan J, Kron T, Schneider-Kolsky M, Hicks RJ (2011) The clinical significance and management of lesion motion due to respiration during PET/CT scanning. Cancer Imaging 11:224–236
Wanigaratne DM, Kron T, Herath S, Atkins S, Cramb J (2011) A robust curve fitting for dose calibration in EBT2 gafchromic film dosimetry. Australas Phys Eng Sci Med 34:627
Gerig LH, Niedbala M, Nyiri BJ (2010) Dose perturbations by two carbon fiber treatment couches and the ability of a commercial treatment planning system to predict these effects. Med Phys 37(1):322–328
Smith DW, Christophides D, Dean C, Naisbit M, Mason J, Morgan A (2010) Dosimetric characterization of the iBEAM evo carbon fiber couch for radiotherapy. Med Phys 37(7):3595–3606
van Prooijen M, Kanesalingam T, Islam MK, Heaton RK (2010) Assessment and management of radiotherapy beam intersections with the treatment couch. J Appl Clin Med Phys 11:2
Clements N, Kron T, Franich R, Dunn L, Roxby P, Aarons Y, Chesson B, Siva S, Duplan D, Ball D (2013) The effect of irregular breathing patterns on internal target volumes in four-dimensional CT and cone-beam CT images in the context of stereotactic lung radiotherapy. Med Phys 40(2):021904–021910
Acknowledgments
This work was supported by Cancer Australia Priority-Driven Collaborative Cancer Research Scheme grant 566813 in support of the CHISEL (TROG 09.02) clinical trial.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hardcastle, N., Clements, N., Chesson, B. et al. Results of patient specific quality assurance for patients undergoing stereotactic ablative radiotherapy for lung lesions. Australas Phys Eng Sci Med 37, 45–52 (2014). https://doi.org/10.1007/s13246-013-0239-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13246-013-0239-4